Reeves, Suzanne

Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial

Howard, R., Zubko, O., Bradley, R., Harper, E., Pank, L., O’Brien, J., Fox, C., Tabet, N., Livingston, G., Bentham, P., et al. (2020) · JAMA Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 194

Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease

Reeves, S., Brown, R., Howard, R., & Grasby, P. (2009) · Neurology

Dementia and Cognitive Impairment ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 98

Clinical and cost-effectiveness of the managing agitation and raising quality of life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial

Livingston, G., Barber, J., Marston, L., Stringer, A., Panca, M., Hunter, R., Cooper, C., Laybourne, A., La Frenais, F., Reeves, S., et al. (2019) · The Lancet Psychiatry

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 62

A Systematic Review of Third-Wave Therapies to Reduce Distress and Improve Wellbeing and Quality of Life in People with Parkinson's Disease.

Christodoulou, D., Reeves, S., Carvalho, N. P., Stellman, J., & Gould, R. L. (2025) · Clinical Gerontologist

Mindfulness and Compassion InterventionsParkinson's Disease Mechanisms and Treatments

Cited by 4